This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
Delivered as Hybrid Event from 15-18 November 2022
Live In-Person Conference Delivered 15-18 NovemberAustria Center Vienna

Michael Panzara, M.D.
Chief Medical Officer at Wave Life Sciences

Profile

Michael A. Panzara, MD, MPH is currently Chief Medical Officer, Head of Therapeutics Discovery and Development at Wave Life Sciences, overseeing therapeutic research and development efforts.  He has 20 years of experience developing therapies for neurological disorders having served in leadership roles at Sanofi, Genzyme, and Biogen before joining Wave in 2016.  Dr. Panzara received his undergraduate degree from the University of Pennsylvania, medical degree from Stanford University, trained in neurology at Massachusetts General Hospital with post-doctoral training in immunology and rheumatology at Brigham and Women's Hospital, and received his Master of Public Health degree from the Harvard School of Public Health.

Agenda Sessions

  • Discovery and Development of Stereopure Oligonucleotides for Treatment of Genetically Defined Neurological Diseases

    09:15